ENG

  • Shan PENG

    Regional Partner / Wuhan

  • Tel +86-27-5942-5163

    Email pengshan@zhonglun.com

  • Practices

    Chinese Mainland Capital Markets, Private Equity & Investment Funds, Litigation & Arbitration

CV

Shan PENG

Since Ms. Peng started to practice law nearly a decade ago, she has led projects with significant market influence and accumulated rich experience in the field of capital markets. She is skilled in domestic IPOs, transfer of listing, refinancing of domestic listed companies, major asset restructuring, listing on the NEEQ, Beijing Stock Exchange listing, private placement, investment, and mergers and acquisitions.

Representative Matters

Domestic Listing

  • Managed the IPO of Hubei Goto Biopharm Co.,Ltd. (300966.SZ)

  • Managed the first public offering of select tier shares by Taixiang

  • Managed the listing of Taixiang shares on the Beijing Stock Exchange (BSE)

  • Managed the transfer of listing of Taixiang (301192.SZ) to ChiNext, the first of its kind in China

  • Managed the listing of an enterprise in Wuhan on the BSE (to be declared)

  • Managed the listing of an enterprise in Hunan on the BSE (to be declared)

  • Managed the listing of an enterprise in Wuhan on the SSE STAR Market (to be declared)


Mergers, Acquisitions, Restructurings, and Refinancings of Listed Companies

  • Managed GotoBiopharm's public convertible bond program

  • Managed Taixiang's acquisition of controlling interest in Hongma Technology and major asset restructuring

  • Managed Xingfa Group's refinancing projects, including the issuance of CNY 800 million corporate bonds and CNY 2 billion ultra-short-term financing bonds

  • Participated in the major asset reorganization project of Dinglong

  • Managed Xingfa Group's acquisition of Inner Mongolia Tenglong, Jingzhou Jinghua, Maple Leaf Chemical and other domestic listed companies


National Equities Exchange and Quotations (NEEQ)

  • Participated in the listing and public transfer of stocks in nearly 20 enterprises on the National Equities Exchange and Quotations (NEEQ), including Precision New Power, Zhuo Yue Technology, Taixiang Stock, Dacheng Science and Technology, Xinkegu, Xianlu Medicine, Ulan Voyage School, Aidi Science and Technology, Sang Zhiyuan, Zhongsheng Water Conservation, Hexite, EWT, Carter Stock, Radiate, Dayang Yitian, and so on

  • Advised on the public offering and transfer of the shares of Taixiang Stock to the National Stock Transfer System, and the listing of Taixiang Stock on the BSE

 

Private Investment and Financing

  • Participated in the investment and establishment of sub-funds by state-owned funds, the establishment of merger and acquisition funds by many listed companies such as Ma Yinglong, Xingfa Group, Tianyu Information, Yanhua Intelligence, and Xingfa Group, as well as the fundraising and establishment of private equity funds, registration and filing, and investment due diligence and post-investment management , and mergers and acquisitions of PE funds

 

Corporate Compliance

  • Provided legal services for listed companies including Xingfa Group, Dinglong, GotoBiopharm, Taixiang, and Tianyu Information for internal control standardization and information disclosure compliance matters

  • Provided legal services for listed companies such as Luban Pharmaceutical, Dayang Yitian, and Reddit on optimization of corporate governance structure

 

Equity Incentive

  • Managed equity incentive projects for Xingfa Group, Dinglong, Tianyu, GotoBiopharm, Taixiang, and other listed companies

  • Provided legal services for equity incentives for Carter, EWT, Luban Pharmaceutical, Reddit, and other companies

  • Bar Admissions/Professional Qualifications

    PRC Bar, 2015

  • Education

    Master of Law, Central China Normal University, 2011 to 2014

  • Professional Experience

    Regional partner, non-equity partner, and associate, Zhong Lun Law Firm, February 2015 to present
    Legal Officer, Wuhan Academy of Agricultural Sciences, June 2014-October 2014

  • Languages

    Chinese
    English